Upstream First-Tier LCD Suppliers to Face Greater

Upstream First-Tier LCD Suppliers to Face Greater Pressure from Chinese Rivals, Says TrendForce

WitsView, a division of TrendForce, reports that upstream LCD component suppliers based in China have significantly expanded their manufacturing capabilities through 2016 and will become stronger competitors against their international first-tier counterparts in 2017
https://en.ctimes.com.tw/DispNews.asp?O=HK0CJ9DEYRISAA00NN



BMS Acquires Exclusive Rights to Nitto Denko NASH Candidate

Nitto Denko has granted Bristol-Myers Squibb (BMS) an exclusive license to develop its lead asset, the Phase Ib advanced nonalcoholic steatohepatitis (NASH) candidate ND-L02-s0201, and other smalll interfering RNA (siRNA) molecules targeting heat shock protein 47 (HSP47) in vitamin A-containing formulations, the companies said today.
http://www.genengnews.com/gen-news-highlights...e/81253418


.....call me crazy; but has anyone thought about ND BMS QMC relationship? QMC received BMS patents, (at what seemed a cheap price) and had been working w/ND for a while, (and of course qds for medicals would necessarily bring higer price/gm for qds......yep, confirms I'm still crazy)

Given what we already know wrt mkts, it would seem that more than one plum can grow on a tree.